These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21827394)

  • 1. VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspective.
    Choueiri TK
    Curr Clin Pharmacol; 2011 Aug; 6(3):164-8. PubMed ID: 21827394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging targeted therapies in metastatic renal cell carcinoma.
    Matrana MR; Atkinson B; Jonasch E; Tannir NM
    Curr Clin Pharmacol; 2011 Aug; 6(3):189-98. PubMed ID: 21827388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging oral VEGF inhibitors for the treatment of renal cell carcinoma.
    Stitzlein L; Rao P; Dudley R
    Expert Opin Investig Drugs; 2019 Feb; 28(2):121-130. PubMed ID: 30572736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy and targeted therapy combinations in renal cancer.
    McDermott DF
    Curr Clin Pharmacol; 2011 Aug; 6(3):207-13. PubMed ID: 21827391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma.
    Albiges L; Salem M; Rini B; Escudier B
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):813-33. PubMed ID: 21763969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicities of targeted agents in advanced renal cell carcinoma.
    Patel P; Srinivas S
    Curr Clin Pharmacol; 2011 Aug; 6(3):181-8. PubMed ID: 21827392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF inhibitors in renal cell carcinoma.
    Vachhani P; George S
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):1016-1028. PubMed ID: 28212363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress?
    Rini BI; Bukowski RM
    Oncology (Williston Park); 2008 Apr; 22(4):388-96; discussion 396, 402-3, 476 passim. PubMed ID: 18472614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy in renal cell carcinoma.
    Favaro JP; George DJ
    Expert Opin Investig Drugs; 2005 Oct; 14(10):1251-8. PubMed ID: 16185167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.
    Choueiri TK; Bukowski RM; Rini BI
    Semin Oncol; 2006 Oct; 33(5):596-606. PubMed ID: 17045089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab as a treatment option in advanced renal cell carcinoma: an analysis and interpretation of clinical trial data.
    McDermott DF; George DJ
    Cancer Treat Rev; 2010 May; 36(3):216-23. PubMed ID: 20116176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms.
    Mulders P
    BJU Int; 2009 Dec; 104(11):1585-9. PubMed ID: 20053190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma.
    Escudier B; Albiges L
    Drugs; 2011 Jun; 71(9):1179-91. PubMed ID: 21711062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of renal cell carcinoma: Current status and future directions.
    Barata PC; Rini BI
    CA Cancer J Clin; 2017 Nov; 67(6):507-524. PubMed ID: 28961310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced renal cell carcinoma: current and emerging management strategies.
    Escudier B
    Drugs; 2007; 67(9):1257-64. PubMed ID: 17547470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach.
    Bukowski RM
    Expert Opin Pharmacother; 2010 Oct; 11(14):2351-62. PubMed ID: 20586712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New drugs for metastatic kidney cancer].
    Doehn C
    Aktuelle Urol; 2008 Jan; 39(1):41-52. PubMed ID: 18228187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): current status and future prospects.
    Sciarra A; Gentile V; Salciccia S; Alfarone A; Di Silverio F
    Rev Recent Clin Trials; 2008 May; 3(2):97-103. PubMed ID: 18474019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination targeted therapy in advanced renal cell carcinoma.
    Sosman J; Puzanov I
    Cancer; 2009 May; 115(10 Suppl):2368-75. PubMed ID: 19402058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-targeted therapy in metastatic renal cell carcinoma.
    Rini BI
    Oncologist; 2005 Mar; 10(3):191-7. PubMed ID: 15793222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.